How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
about
Drugs versus placebo for dysthymiaDrugs versus placebo for dysthymiaAntidepressants and the Placebo EffectChallenging received wisdom: antidepressants and the placebo effectLessons learned from placebo groups in antidepressant trialsAssociation between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group.A randomised cross-over study assessing the "blue pyjama syndrome" in major depressive episode.Perceived drug assignment and treatment outcome in smokers given nicotine patch therapyPractical aspects of conducting a pragmatic randomised trial in primary care: patient recruitment and outcome assessment.Can acupuncture treatment be double-blinded? An evaluation of double-blind acupuncture treatment of postoperative pain.Study blinding and correlations between perceived group assignment and outcome in a cocaine pharmacotherapy trial.Blindness and bias in a trial of antidepressant medication for chronic tension-type headache.Learning to experience side effects after antidepressant intake - Results from a randomized, controlled, double-blind study.Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.Improving study design for antidepressant effectiveness assessment.Nocebo vs. placebo: the challenges of trial design in analgesia research.Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression.Hypnosis, placebos, and systematic research bias in biological psychiatry.The use of placebos in clinical trials and clinical practice.‘Placebos’ and the logic of placebo comparison
P2860
Q24187378-C6841F87-403A-4922-A175-2DBCA6788D03Q24246945-F5F93120-FC82-42AE-B80C-5F7BB3343788Q28468667-7245610A-E103-42E8-ADA7-394B2329713FQ28474068-DF77670B-CB07-46F7-88A2-4CD85DC0D41EQ28478927-EBD2FD52-F682-415A-88DE-67B6FDBB7008Q30882051-2E1CCB6B-469C-44C2-BF68-9F012DAB1AFDQ33752833-3DB54A6B-D0E9-481A-ABDF-3816E24A6FEBQ34023285-6A1F00AD-C1A4-4512-9D00-814B0FC59266Q34218465-8FDDD7CD-95C4-41C4-858E-4DF3BA3D1F41Q35154698-3A6224B7-F897-47A0-B551-13A661EEAF6FQ35212082-504CC641-90EE-4E98-801A-7D75CF263625Q36248812-5A65119B-C5E3-4D24-9488-B5ACA40295D8Q37578354-9BA2920F-982D-4E2A-84E5-BEB3615842F5Q37737462-67A694E8-094E-4564-A8F1-81BDCDC52E24Q38137886-5ACBA7F5-CA3C-4C55-8CA5-B9CA6E0B83DCQ38351533-ACE6E85E-E1F0-4CAB-ABB5-B0A7CABA55CDQ47604119-C7D0A465-86FA-4F1A-92EE-B4438F476EB0Q48389749-243FD566-9CEC-44BC-9C03-84845513E68CQ48686992-D1FC07E5-8E28-4D10-9D4E-E02103C98EA3Q55980444-5E523971-9B3E-47D6-B947-36676F14B03C
P2860
How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
description
1986 nî lūn-bûn
@nan
1986 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
How blind is blind? Assessment ...... of imipramine and phenelzine.
@ast
How blind is blind? Assessment ...... of imipramine and phenelzine.
@en
How blind is blind? Assessment ...... of imipramine and phenelzine.
@nl
type
label
How blind is blind? Assessment ...... of imipramine and phenelzine.
@ast
How blind is blind? Assessment ...... of imipramine and phenelzine.
@en
How blind is blind? Assessment ...... of imipramine and phenelzine.
@nl
prefLabel
How blind is blind? Assessment ...... of imipramine and phenelzine.
@ast
How blind is blind? Assessment ...... of imipramine and phenelzine.
@en
How blind is blind? Assessment ...... of imipramine and phenelzine.
@nl
P2093
P1433
P1476
How blind is blind? Assessment ...... of imipramine and phenelzine.
@en
P2093
Harrison W
Markowitz JS
Quitkin FM
P356
10.1016/0165-1781(86)90094-6
P407
P577
1986-09-01T00:00:00Z